Cargando…
C(60) fullerene and its nanocomplexes with anticancer drugs modulate circulating phagocyte functions and dramatically increase ROS generation in transformed monocytes
BACKGROUND: C(60) fullerene-based nanoformulations are proposed to have a direct toxic effect on tumor cells. Previous investigations demonstrated that C(60) fullerene used alone or being conjugated with chemotherapeutic agents possesses a potent anticancer activity. The main aim of this study was t...
Autores principales: | Skivka, Larysa M., Prylutska, Svitlana V., Rudyk, Mariia P., Khranovska, Nataliia M., Opeida, Ievgeniia V., Hurmach, Vasyl V., Prylutskyy, Yuriy I., Sukhodub, Leonid F., Ritter, Uwe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208740/ https://www.ncbi.nlm.nih.gov/pubmed/30416604 http://dx.doi.org/10.1186/s12645-017-0034-0 |
Ejemplares similares
-
A nanocomplex of C(60) fullerene with cisplatin: design, characterization and toxicity
por: Prylutska, Svitlana, et al.
Publicado: (2017) -
C(60) fullerene against SARS-CoV-2 coronavirus: an in silico insight
por: Hurmach, Vasyl V., et al.
Publicado: (2021) -
Synergy of Chemo- and Photodynamic Therapies with C(60) Fullerene-Doxorubicin Nanocomplex
por: Grebinyk, Anna, et al.
Publicado: (2019) -
Sex-based differences in phagocyte metabolic profile in rats with monosodium glutamate-induced obesity
por: Rudyk, Mariia P., et al.
Publicado: (2018) -
Complex of C(60) Fullerene with Doxorubicin as a Promising Agent in Antitumor Therapy
por: Prylutska, Svitlana V., et al.
Publicado: (2015)